01:13 AM EDT, 07/21/2026 (MT Newswires) -- Advicenne (ALDVI.PA) said Monday the Spanish health authorities approved the reimbursement of Sibnayal, a prescription medicine to treat distal renal tubular acidosis. The specialty pharmaceutical company distributes the medicines in the country through its partner SPA Farma Iberica. It was previously available through an early access program, which will conclude with the official reimbursement.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.